VSee Health (NASDAQ: VSEE), the San Jose, California-based telehealth platform company, used the HIMSS 2026 stage in Las Vegas to debut what it describes as the world’s first fully autonomous telehealth AI robot purpose-built for hospital and health system deployment. The VSee AI Robot navigates hospital corridors and positions itself at patient bedsides without requiring a staff escort, a capability the company says sets it apart from the telepresence carts that have populated hospital floors for more than a decade.
HotSpot Take
Hospital telehealth robots have existed for years, but VSee’s new autonomous model navigates to patients without a staff escort, addressing a friction point that has limited real-world adoption.
Autonomous Navigation as the Core Differentiator
The limitations of earlier hospital telehealth robots are well-documented in the industry. Traditional telepresence carts rely on staff to physically reposition or escort them, adding a labor burden that has constrained practical utilization. VSee Health addresses that friction point directly.
The VSee AI Robot uses LiDAR-based mapping to build a detailed model of a hospital’s physical layout, then navigates autonomously, including at night, aided by 30x optical zoom and infrared night vision. The system is designed to operate without internet connectivity, a notable engineering choice for a hospital environment where Wi-Fi coverage can be inconsistent in corridors or older facility sections. According to the company, the robot self-monitors its battery level and returns to a charging station autonomously when needed, without staff intervention.
“We built the VSee AI Robot to solve the hardest problem in healthcare staffing: doing more with less, without sacrificing the human connection at the bedside.”— Dr. Milton Chen, CEO, VSee
“We built the VSee AI Robot to solve the hardest problem in healthcare staffing: doing more with less, without sacrificing the human connection at the bedside,” said Dr. Milton Chen, CEO of VSee. “This isn’t a cart with a screen. This is an autonomous clinical teammate that multiplies what every provider on your team can do.”
Clinical and Operational Capabilities
VSee is positioning the robot as a multi-function clinical tool rather than a single-use telepresence device. The system integrates built-in medical devices supporting remote physical examination, a surgical-grade display for high-definition virtual encounters, and programmable drawers for medication and supply delivery. According to the company, a remote physician can instruct the robot to navigate to a specific patient or room, conduct a virtual examination, and complete a delivery task, all in a single autonomous pass.
The robot is offered in two models. The smaller form factor, designed for general virtual rounding and specialist coverage, is priced at $3,000 per month under a lease-based model that includes maintenance and hardware support. The larger model, which according to the company carries up to 60 kilograms of payload capacity for more substantial supply and medication delivery, is priced at $5,000 per month. VSee is offering a show-special rate of $2,500 per month for the smaller model to HIMSS 2026 attendees.
The VSee AI Workflow Engine: Platform Integration
The robot operates within VSee’s broader AI Workflow Engine, a no-code/low-code platform the company describes as a secure middleware layer that connects clinical AI modules (including AI-assisted scheduling, early warning vitals alerts, and stroke CT hemorrhage notifications) without requiring lengthy IT integration projects. According to VSee, the modular building-blocks architecture enables health systems to configure and activate capabilities in days rather than months.
The platform architecture is a meaningful element of the robot’s market positioning because the robot does not support third-party telehealth software integration. As a proprietary end-to-end system, VSee’s platform handles the full workflow from a remote physician directing the robot to a specific patient through the completion of a virtual encounter and any associated documentation. The company argues that this closed approach is necessary for the robot control logic to function reliably, but health systems operating mixed-vendor environments will need to account for it during procurement evaluation.
Security Credentials and Federal Deployment History
VSee has been in operation since 2008 and holds FedRAMP High Authority to Operate (ATO) certification from the U.S. Department of Health and Human Services, a security designation the company notes distinguishes it from many commercial telehealth platforms. According to VSee, this certification qualifies the platform to store sensitive records, including those of federal officials. The company’s federal deployment history includes serving as the telehealth platform for the NASA Space Station for more than a decade, in addition to contracts with clients including McKesson, DaVita, and the LA County Department of Mental Health.
The company’s telehealth platform currently supports more than 1.5 million video encounters per month, according to VSee, with capacity for more than 1,800 appointments per day.
Competitive Context
The hospital telehealth robot market is not new. InTouch Health (now part of Teladoc Health) launched one of the early commercial hospital robot systems more than a decade ago. Other vendors, including Ava Robotics (with which VSee previously announced a partnership for ICU telepresence), have pursued the autonomous navigation challenge in healthcare settings. The VSee AI Robot enters a market where prior-generation devices have faced adoption barriers related to cost, navigation reliability, and staff burden. VSee’s HIMSS 2026 launch directly addresses those criticisms, while its proprietary platform architecture introduces interoperability considerations that will factor into health system decision-making.
The broader market backdrop is favorable. AI-driven robotics platforms have been identified by analysts as a focal area for medtech investment and acquisition activity heading into 2026, as health systems seek technologies that extend clinical capacity without proportionally increasing headcount.
Live Demonstration at HIMSS 2026
The VSee AI Robot is on live demonstration at HIMSS 2026 at Booth #4468 at the Venetian Convention and Expo Center through March 12. The robot is also appearing at the Onyx Healthcare Booth #2248, where the display hardware powering the robot’s bedside interface (the Onyx Venus-154 Plus, a 15.6-inch clinical-grade medical AI panel PC) is also on exhibit.
For a healthcare workforce navigating persistent staffing shortages and the continuing pressure to extend specialist coverage across more facilities, an autonomous robot that eliminates the need for an on-site escort could represent a practical step toward closing coverage gaps, assuming the technology performs as advertised in real-world hospital environments.
— This original article was created with AI support.
